Purpose: Testicular cancer is a model for a curable neoplasm. We revie
w past and present accomplishments in treating testis cancer and empha
size controversial surgical issues of interest to the urologist. Mater
ials and Methods: We reviewed early and recent chemotherapy trials of
germ cell tumors, stressing random prospective phase III studies. In a
ddition, we address specific and complicated issues that are of partic
ular relevance for the urologist, analyzing recently published article
s. Results: Cisplatin combination chemotherapy has dramatically improv
ed the cure rate for patients with germ cell tumors. The indications f
or post-chemotherapy resection for residual masses are discussed. Conc
lusions: The major goal 25 years ago was to develop a successful chemo
therapy regimen for disseminated disease, which has now been accomplis
hed with cisplatin combination chemotherapy. Present issues include op
timal treatment in patients with poor prognostic characteristics, salv
age chemotherapy strategies and indications for past-chemotherapy surg
ical resection.